CytomX Therapeutics, Inc. (CTMX): Net Income
-$17.37M
Year ended 2025-12-31
-$79.65M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$17.37M | n/m | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | $31.87M | n/m | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | -$569.0K | n/m | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | -$99.32M | n/m | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | -$115.87M | n/m | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | -$64.82M | n/m | 2023-03-27, From 2020-01-01 |
| 2019-12-31 | -$132.82M | n/c | 2023-03-27, From 2019-01-01 |
| 2018-12-31 | -$84.60M | n/m | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | -$43.10M | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | -$58.90M | n/m | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | -$35.37M | n/m | 2018-03-07, From 2015-01-01 |
| 2014-12-31 | -$30.31M | n/m | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | -$15.14M | n/a | 2016-03-07, From 2013-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | -$17.37M | n/m |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | -$146.41M | n/m |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | -$4.60M | n/m |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | -$218.96M | n/m |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$6.12M | n/m |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | -$142.62M | n/m |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | -$342.60M | n/m |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | -$65.78M | n/m |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | -$5.31M | n/m |
Compare CTMX, ABCL, ETON, BCYC side by side · Screen every company in Pharmaceutical Preparations ↗